» Articles » PMID: 29609536

Effects of Dialysate to Serum Sodium (Na) Alignment in Chronic Hemodialysis (HD) Patients: Retrospective Cohort Study from a Quality Improvement Project

Overview
Journal BMC Nephrol
Publisher Biomed Central
Specialty Nephrology
Date 2018 Apr 4
PMID 29609536
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Evidence indicates favorable effects of dialysate (DNa) to serum sodium concentration (SNa) alignment, however, results from larger sample populations are needed. For this reason, we conducted a retrospective propensity score-matched cohort study from a quality improvement project to investigate the effects of alignment on population of maintenance hemodialysis patients.

Methods: At 4 participating hemodialysis (HD) clinics, patients with SNa lower than the standard DNa of 137 mEq/L who received HD with DNa aligned to the average of the last 4 SNa measurements were evaluated (clinicaltrials.gov # NCT01825590 ). In this retrospective data analysis, an intention-to-treat (primary) and an as-treated "intervention" (secondary) cohort were created. "Aligned" patients from both cohorts (N = 163 for the primary and N = 137 for the secondary) were then propensity-score matched in a 1:1 fashion to "unaligned" patients from the Renal Research Institute database. The propensity score was generated based on age, gender, white race, Hispanic ethnicity, absence or presence of diabetes, hemodialysis vintage, interdialytic weight gain (IDWG; as a percentage of postdialysis body weight), catheter as primary dialysis access, predialysis systolic blood pressure, serum sodium concentration, hospitalization count during baseline. T-Test was employed for group comparisons of changes to the primary (volume-related and hemodynamic parameters) and tertiary outcomes. All-cause and fluid overload-related hospitalization admission rates were compared using Wilcoxon Rank Sum test and Cox regression analysis for repeated events.

Results: In the primary analysis, aligned and unaligned subjects showed comparable demographics at baseline. Treatment effects were significant for IDWG [-0.12 (95% CI -0.24 to 0) L] and showed decreasing non-significant trends for pre-dialysis hemodynamic parameters. Count comparison and Cox regression analysis showed no clear advantage of alignment in terms of all-cause and fluid overload-related hospitalization.

Conclusions: Results from the largest sodium alignment program to date suggest positive treatment effects on volume-related and hemodynamic parameters, but no clear effect on risk of hospitalization. Well-matched control patients minimized confounding effects. Small effects and lack of significant differences may be explained by a low baseline DNa limiting the interventional change.

Citing Articles

Low dialysate sodium levels for chronic haemodialysis.

Marshall M, Wang M, Vandal A, Dunlop J Cochrane Database Syst Rev. 2024; 11:CD011204.

PMID: 39498822 PMC: 11536490. DOI: 10.1002/14651858.CD011204.pub3.


Proceedings of a membrane update symposium: advancements, scientific insights, and future trends for dialysis membranes for enhanced clinical outcomes in end stage kidney disease patients.

Wanner C, Vanholder R, Ortiz A, Davenport A, Canaud B, Blankestijn P Front Nephrol. 2024; 4:1455260.

PMID: 39473870 PMC: 11520239. DOI: 10.3389/fneph.2024.1455260.


Hemodialysis Procedures for Stable Incident and Prevalent Patients Optimize Hemodynamic Stability, Dialysis Dose, Electrolytes, and Fluid Balance.

Stuard S, Ridel C, Cioffi M, Trost-Rupnik A, Gurevich K, Bojic M J Clin Med. 2024; 13(11).

PMID: 38892922 PMC: 11173331. DOI: 10.3390/jcm13113211.


Changes in serum sodium concentration during hemodialysis is a predictor of mortality and cardio-cerebrovascular event.

Liu Q, Zheng K, Wang H, Song D, Li X Ren Fail. 2024; 46(1):2338483.

PMID: 38604948 PMC: 11011235. DOI: 10.1080/0886022X.2024.2338483.


Feedback control in hemodialysis.

Randhay A, Eldehni M, Selby N Semin Dial. 2023; 38(1):62-70.

PMID: 37994191 PMC: 11867153. DOI: 10.1111/sdi.13185.


References
1.
de Paula F, Peixoto A, Pinto L, Dorigo D, Patricio P, Santos S . Clinical consequences of an individualized dialysate sodium prescription in hemodialysis patients. Kidney Int. 2004; 66(3):1232-8. DOI: 10.1111/j.1523-1755.2004.00876.x. View

2.
Dunlop J, Vandal A, de Zoysa J, Gabriel R, Haloob I, Hood C . Rationale and design of the Sodium Lowering In Dialysate (SoLID) trial: a randomised controlled trial of low versus standard dialysate sodium concentration during hemodialysis for regression of left ventricular mass. BMC Nephrol. 2013; 14:149. PMC: 3720185. DOI: 10.1186/1471-2369-14-149. View

3.
Cheung A, Yan G, Greene T, Daugirdas J, Dwyer J, Levin N . Seasonal variations in clinical and laboratory variables among chronic hemodialysis patients. J Am Soc Nephrol. 2002; 13(9):2345-52. DOI: 10.1097/01.asn.0000026611.07106.a7. View

4.
Peixoto A, Gowda N, Parikh C, Santos S . Long-term stability of serum sodium in hemodialysis patients. Blood Purif. 2010; 29(3):264-7. DOI: 10.1159/000274460. View

5.
Mendoza J, Sun S, Chertow G, Moran J, Doss S, Schiller B . Dialysate sodium and sodium gradient in maintenance hemodialysis: a neglected sodium restriction approach?. Nephrol Dial Transplant. 2011; 26(4):1281-7. PMC: 3108351. DOI: 10.1093/ndt/gfq807. View